We postulated that some of the anti-Aβ-antibodies that we use would prevent Aβ from suppressing BK channels and would thereby narrow action potentials in 3xTg-AD mouse neocortical pyramidal neurons. Here, KCNMA1 is linked to Alzheimer disease.